UTRECHT, Niederlande, 13. März 2025 /PRNewswire/ — Die Turacoz Group, ein führendes Unternehmen in den Bereichen Real-World Evidence (RWE) und Health Economics and Outcomes Research (HEOR), präsentierte auf der World EPA 2025 Conference Erkenntnisse über […]
PITTSBURGH, March 13, 2025 /PRNewswire/ — Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 revolution. These innovations integrate AI and […]
Brexpiprazole’s indication for the treatment of schizophrenia in adults is extended to include adolescents aged 13 years and older1 Approval follows a positive Committee for Medicinal Products for Human Use (CHMP) opinion from the European […]
SHANGHAI, March 13, 2025 /PRNewswire/ — WuXi XDC Cayman Inc. (“WuXi XDC”, or the “Company”, stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other […]
SHANGHAI, March 13, 2025 /PRNewswire/ — BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA), to […]
